Evidence map›Paper›PMID 37383086›Full record

ArticleJournal of liver cancer2021

Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report.

Dong Jin Joo, Do Young Kim, Jinsil Seong, Hyun Jeong Kim, Jae Geun Lee, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of liver cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Dong Jin JooDepartment of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8405-1531
Do Young KimDepartment of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8327-3439
Jinsil SeongDepartment of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1794-5951
Hyun Jeong KimDepartment of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-6033-5094
Jae Geun LeeDepartment of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-6722-0257
Dai Hoon HanDepartment of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-2787-7876
Gi Hong ChoiDepartment of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1593-3773
Myoung Soo KimDepartment of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8975-8381
Jin Sub ChoiDepartment of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-6467-6494
Soon Il KimDepartment of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0783-7538
Yonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) with distant metastasis is an absolute contraindication for liver transplantation (LT). However, it is still unclear whether LT is feasible or acceptable in such patients, albeit after being treated with a multidisciplinary approach and after any metastatic lesion is ruled out. We report one such successful treatment with living donor LT (LDLT) after completely controlling far-advanced HCC with inferior vena cava tumor thrombosis and multiple lung metastases. The patient has been doing well without HCC recurrence for eight years since LDLT. The current patient could be an anecdotal case, but provides a case for expanding LDLT indications in the context of advanced HCC and suchlike.

Indexed as

Case reportHepatocellular carcinomaLiver transplantationNeoplasm metastasisRadiotherapy

Identifiers

PMID37383086
PMCPMC10035687
OpenAlexW3201736136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.